{ "cik": 200406, "cik_padded": "0000200406", "entityName": "JOHNSON & JOHNSON", "fiscal_years": [ { "accn": "0000200406-26-000016", "filed": "2026-02-11", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5953000000.0, "capex": 4832000000.0, "cash": 19709000000.0, "cost_of_revenue": 30256000000.0, "eps_diluted": 11.03, "free_cash_flow": 19698000000.0, "gross_profit": 63937000000.0, "net_income": 26804000000.0, "operating_cash_flow": 24530000000.0, "revenue": 94193000000.0, "stockholders_equity": 81544000000.0, "total_assets": 199210000000.0, "total_liabilities": 117666000000.0 }, "period_end": "2025-12-28", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6787871710212011, "leverage": 1.4429755714706172, "net_margin": 0.2845646704107524, "revenue_growth_yoy": 0.06048119251078011, "roa_avg2y": 0.14132881992228075, "roa_period_end": 0.13455147833944078, "roe_avg2y": 0.35030124024726533, "roe_period_end": 0.3287059746885117 } }, { "accn": "0000200406-26-000016", "filed": "2026-02-11", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2432000000.0, "capex": 4424000000.0, "cash": 24105000000.0, "cost_of_revenue": 27471000000.0, "eps_diluted": 5.79, "free_cash_flow": 19842000000.0, "gross_profit": 61350000000.0, "net_income": 14066000000.0, "operating_cash_flow": 24266000000.0, "revenue": 88821000000.0, "stockholders_equity": 71490000000.0, "total_assets": 180104000000.0, "total_liabilities": 108614000000.0 }, "period_end": "2024-12-29", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6907150336069173, "leverage": 1.5192894111064486, "net_margin": 0.1583634500850024, "revenue_growth_yoy": 0.04300191406662831, "roa_avg2y": 0.08091767291219633, "roa_period_end": 0.07809932039266201, "roe_avg2y": 0.20056464951805167, "roe_period_end": 0.19675479087984332 } }, { "accn": "0000200406-26-000016", "filed": "2026-02-11", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5054000000.0, "capex": 4543000000.0, "cash": 21859000000.0, "cost_of_revenue": 26553000000.0, "eps_diluted": 13.72, "free_cash_flow": 18248000000.0, "gross_profit": 58606000000.0, "net_income": 35153000000.0, "operating_cash_flow": 22791000000.0, "revenue": 85159000000.0, "stockholders_equity": 68774000000.0, "total_assets": 167558000000.0, "total_liabilities": 98784000000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6881950234267664, "leverage": 1.4363567627301015, "net_margin": 0.41279254101151963, "revenue_growth_yoy": 0.08152146304292608, "roa_avg2y": 0.2011179257157242, "roa_period_end": 0.20979601093352748, "roe_avg2y": 0.49234927904647857, "roe_period_end": 0.511137930031698 } }, { "accn": "0000200406-25-000038", "filed": "2025-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3456000000.0, "capex": 3652000000.0, "cash": 14487000000.0, "cost_of_revenue": 23402000000.0, "eps_diluted": 7.81, "free_cash_flow": 19758000000.0, "gross_profit": 55338000000.0, "net_income": 20878000000.0, "operating_cash_flow": 23410000000.0, "revenue": 78740000000.0, "stockholders_equity": 74023000000.0, "total_assets": 182018000000.0, "total_liabilities": 107995000000.0 }, "period_end": "2022-01-02", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7027940055880112, "leverage": 1.4589384380530375, "net_margin": 0.2651511303022606, "revenue_growth_yoy": -0.046546546546546545, "roa_avg2y": 0.11699242390281078, "roa_period_end": 0.1147029414673274, "roe_avg2y": 0.3041201447913708, "roe_period_end": 0.28204747173175904 } }, { "accn": "0000200406-24-000013", "filed": "2024-02-16", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3221000000.0, "capex": 3347000000.0, "cash": 13985000000.0, "cost_of_revenue": 28427000000.0, "eps_diluted": 5.51, "free_cash_flow": 20189000000.0, "gross_profit": 54157000000.0, "net_income": 14714000000.0, "operating_cash_flow": 23536000000.0, "revenue": 82584000000.0, "stockholders_equity": 63278000000.0, "total_assets": 174894000000.0, "total_liabilities": 111616000000.0 }, "period_end": "2021-01-03", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6557807807807807, "leverage": 1.7638989854293752, "net_margin": 0.17817010558946042, "roa_period_end": 0.08413095932393336, "roe_period_end": 0.23252947311861946 } }, { "accn": "0000200406-23-000016", "filed": "2023-02-16", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 6746000000.0, "capex": 3498000000.0, "cash": 17305000000.0, "cost_of_revenue": 27556000000.0, "eps_diluted": 5.63, "free_cash_flow": 19918000000.0, "gross_profit": 54503000000.0, "net_income": 15119000000.0, "operating_cash_flow": 23416000000.0, "revenue": 82059000000.0, "stockholders_equity": 59471000000.0, "total_assets": 157728000000.0, "total_liabilities": 98257000000.0 }, "period_end": "2019-12-29", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6641928368612827, "leverage": 1.6521834171276757, "net_margin": 0.1842454819093579, "revenue_growth_yoy": 0.0058592074134908865, "roa_avg2y": 0.09732781429242762, "roa_period_end": 0.09585488942990467, "roe_avg2y": 0.25362555882673643, "roe_period_end": 0.2542247481966 } }, { "accn": "0000200406-22-000022", "filed": "2022-02-17", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5868000000.0, "capex": 3670000000.0, "cash": 18107000000.0, "cost_of_revenue": 27091000000.0, "eps_diluted": 5.61, "free_cash_flow": 18531000000.0, "gross_profit": 54490000000.0, "net_income": 15297000000.0, "operating_cash_flow": 22201000000.0, "revenue": 81581000000.0, "stockholders_equity": 59752000000.0, "total_assets": 152954000000.0, "total_liabilities": 93202000000.0 }, "period_end": "2018-12-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6679251296257707, "leverage": 1.5598138974427633, "net_margin": 0.18750689498780354, "revenue_growth_yoy": 0.06711576193590582, "roa_avg2y": 0.09860857289279533, "roa_period_end": 0.10001046066137531, "roe_avg2y": 0.2551371005403963, "roe_period_end": 0.25600816709064134 } }, { "accn": "0000200406-21-000008", "filed": "2021-02-22", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 6358000000.0, "capex": 3279000000.0, "cash": 17824000000.0, "cost_of_revenue": 25439000000.0, "eps_diluted": 0.47, "free_cash_flow": 17777000000.0, "gross_profit": 51011000000.0, "net_income": 1300000000.0, "operating_cash_flow": 21056000000.0, "revenue": 76450000000.0, "stockholders_equity": 60160000000.0, "total_assets": 157303000000.0, "total_liabilities": 97143000000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6672465663832571, "leverage": 1.6147440159574469, "net_margin": 0.017004578155657292, "roa_avg2y": 0.008943497733167305, "roa_period_end": 0.008264305194433672, "roe_avg2y": 0.019800472165105474, "roe_period_end": 0.021609042553191495 } }, { "accn": "0000200406-19-000009", "filed": "2019-02-20", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5290000000.0, "capex": 3463000000.0, "cash": 13732000000.0, "eps_diluted": 5.48, "free_cash_flow": 16106000000.0, "gross_profit": 48538000000.0, "net_income": 15409000000.0, "operating_cash_flow": 19569000000.0, "stockholders_equity": 71150000000.0, "total_assets": 133411000000.0, "total_liabilities": 62261000000.0 }, "period_end": "2016-01-03", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8750667603654252, "roa_period_end": 0.1155002211211969, "roe_period_end": 0.2165706254392129 } }, { "accn": "0000200406-18-000005", "filed": "2018-02-21", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 7124000000.0, "capex": 3714000000.0, "cash": 14523000000.0, "eps_diluted": 5.7, "free_cash_flow": 14996000000.0, "gross_profit": 51585000000.0, "net_income": 16323000000.0, "operating_cash_flow": 18710000000.0, "stockholders_equity": 69752000000.0, "total_assets": 130358000000.0, "total_liabilities": 60606000000.0 }, "period_end": "2014-12-28", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8688783117329969, "roa_period_end": 0.12521671090381872, "roe_period_end": 0.2340147952746875 } } ], "latest_filing": { "accn": "0000200406-26-000016", "filed": "2026-02-11", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000200406.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000200406.json" }, "ticker": "JNJ" }